B. Riley Financial’s Envoy Medical COCH Stock Holding History

B. Riley Financial’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,363	Closed	-$255K	–	30
2023 Q1	$255K	Buy	+25,363	New	+$254K	0.07%	26

Other funds holding COCH

Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Longfellow Investment Management Boston, Massachusetts $480M AUM 8% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

B. Riley Financial's COCH Position: Q2 2023 in Review

B. Riley Financial sold out of Envoy Medical (COCH) in Q2 2023, closing a stake of 25,363 shares — an estimated $255K sold.

B. Riley Financial first reported a position in COCH in Q1 2023 and held it in 1 quarter. The position peaked at $255K in Q1 2023. 21 funds tracked by Wall St. Rank hold COCH as of Q2 2023.

B. Riley Financial reported no remaining Envoy Medical position as of Q2 2023 after selling out during the quarter.
B. Riley Financial sold 25,363 Envoy Medical shares in Q2 2023, an estimated $255K.
B. Riley Financial first reported a position in Envoy Medical in Q1 2023 and held it in 1 quarter.
B. Riley Financial's Envoy Medical position peaked at $255K in Q1 2023.
21 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2023.

Based on B. Riley Financial's 13F filing for Q2 2023, filed 8 Aug 2023.